Skip to content

Disease perception and coping in type 2 diabetes patients with mild cognitive impairment: A qualitative study

A qualitative study of disease perception and coping in patients with type 2 diabetes mellitus combined with mild cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100592
Enrollment
Unknown
Registered
2025-04-11
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease perception and coping in type 2 diabetes patients with mild cognitive impairment

Interventions

Observation group:None

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age>=18 years; (2) Meet the diagnostic criteria for type 2 diabetes released by the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition); (3) According to the clinical dementia grading score of the American Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, there is at least one cognitive domain >=0.5 points, and the overall score is <=0.5 points, or the ability to perform daily activities is normal or slightly impaired, and the total score is <=1.5 points; (4) Meet the score requirements of the Montreal Cognitive Assessment Scale, i.e., < = 13 points in the illiterate group, < = 19 points in the primary school group, and < = 24 points in the junior high school group and above; (5) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe infection, brain tumor, subdural hematoma, central nervous system infection, severe heart, liver and kidney insufficiency, cerebral infarction and other complications before the diabetic complications are not corrected; (2) Those with severe mental and behavioral symptoms.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment, MOCA;

Countries

China

Contacts

Public ContactSun Shuxian

Xuzhou Central Hospital

1719130347@qq.com+86 188 5218 1152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026